These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 23879463
1. A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L. Anglin JL, Song Y. J Med Chem; 2013 Nov 27; 56(22):8972-83. PubMed ID: 23879463 [Abstract] [Full Text] [Related]
2. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. Feng Z, Yao Y, Zhou C, Chen F, Wu F, Wei L, Liu W, Dong S, Redell M, Mo Q, Song Y. J Hematol Oncol; 2016 Mar 12; 9():24. PubMed ID: 26970896 [Abstract] [Full Text] [Related]
3. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L. Anglin JL, Deng L, Yao Y, Cai G, Liu Z, Jiang H, Cheng G, Chen P, Dong S, Song Y. J Med Chem; 2012 Sep 27; 55(18):8066-74. PubMed ID: 22924785 [Abstract] [Full Text] [Related]
5. DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy. Liu W, Deng L, Song Y, Redell M. PLoS One; 2014 Sep 27; 9(5):e98270. PubMed ID: 24858818 [Abstract] [Full Text] [Related]
7. Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias. Yi Y, Ge S. J Hematol Oncol; 2022 Mar 24; 15(1):35. PubMed ID: 35331314 [Abstract] [Full Text] [Related]
11. The diverse functions of Dot1 and H3K79 methylation. Nguyen AT, Zhang Y. Genes Dev; 2011 Jul 01; 25(13):1345-58. PubMed ID: 21724828 [Abstract] [Full Text] [Related]
12. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth. Wu F, Nie S, Yao Y, Huo T, Li X, Wu X, Zhao J, Lin YL, Zhang Y, Mo Q, Song Y. Theranostics; 2021 Jul 01; 11(17):8172-8184. PubMed ID: 34373735 [Abstract] [Full Text] [Related]
16. The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79. Chen S, Yang Z, Wilkinson AW, Deshpande AJ, Sidoli S, Krajewski K, Strahl BD, Garcia BA, Armstrong SA, Patel DJ, Gozani O. Mol Cell; 2015 Oct 15; 60(2):319-27. PubMed ID: 26439302 [Abstract] [Full Text] [Related]
17. The emerging roles of DOT1L in leukemia and normal development. McLean CM, Karemaker ID, van Leeuwen F. Leukemia; 2014 Nov 15; 28(11):2131-8. PubMed ID: 24854991 [Abstract] [Full Text] [Related]
19. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development. Barry ER, Corry GN, Rasmussen TP. Expert Opin Ther Targets; 2010 Apr 15; 14(4):405-18. PubMed ID: 20230194 [Abstract] [Full Text] [Related]